Psychiatric comorbidities in children and adolescents with psoriasis - a population-based cohort study

Abstract

Psoriasis is present in 2-3% of the adult European population¹ and 0.7-1.2% in children^1,2.

Adults with psoriasis have increased risk of depression³, and US data reported an increased risk of psychiatric diseases in pediatrics with psoriasis⁴, however European data are lacking.

Primary outcomes were to examine the risk of psychiatric disorders including use of psychopharmacotherapy in children with psoriasis compared to healthy controls in a population-based cohort study.

This article is protected by copyright. All rights reserved.

http://ift.tt/2d76zS0